Zhongyuan Wang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Metabolic subtyping reveals PDIK1L as a dual-functional regulator of progression and PARP inhibitor sensitivity in prostate cancer.
Journal: Frontiers in cell and developmental biology
Published: July 28, 2025
Hsa_circ_0038737 promotes PARPi resistance in castration-resistant prostate cancer via IGF2BP3-mediated DNPH1 mRNA stabilization.
Journal: Molecular cancer
Published: May 27, 2025
Interferon Regulatory Factor 4 Recruits Immature B Cells to Signal Tertiary Lymphoid Structure Immaturity and Progression of Clear Cell Renal Cell Carcinoma.
Journal: International journal of biological sciences
Published: March 13, 2025
Spatial and maturity heterogeneity of tertiary lymphoid structures shapes immune microenvironment and progression in prostate cancer.
Journal: Journal of the National Cancer Center
Published: February 22, 2025
Stratification system with tumor-associated macrophages for predicting prognostic and therapeutic implications in clear cell renal cell carcinoma.
Journal: Journal of the National Cancer Center
Published: May 27, 2024
Prostate cancer in China: epidemiological trends, genomic insights, and future directions for optimized management.
Journal: Journal of the National Cancer Center
Published: April 30, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026